Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katalin Dankó

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Orvosi Hetilap|September 17, 2011
[New therapeutic approaches for polymyositis and dermatomyositis]Katalin Dankó, Melinda Vincze
Orvosi Hetilap|July 26, 2016
[New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis]Andrea Váncsa, Katalin Dankó
Orvosi Hetilap|July 16, 2008
[Inclusion body myositis pathomechanism and therapy]Andrea Váncsa, Katalin Dankó
Clinical Rheumatology|August 5, 2004
Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlapAndrea Ponyi, Tamás Constantin, Katalin Dankó
Orvosi Hetilap|March 14, 2012
[Polymyositis-dermatomyositis recognized during the follow-up of a patient with type 2 diabetes]Francis Samer, Mária Csóka, Katalin Dankó
Orvosi Hetilap|August 30, 2017
[Clinical features and therapeutic response of our anti-SRP positive patients with myositis]Balázs Botos, Melinda Nagy-Vincze, Katalin Dankó
Expert Review of Clinical Pharmacology|July 11, 2017
Pharmacological management of dermatomyositisZoltán Griger, Melinda Nagy-Vincze, Katalin Dankó
Current Opinion in Rheumatology|September 17, 2014
Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic researchLisa G Rider, Katalin Dankó, Frederick W Miller
Orvosi Hetilap|May 8, 2013
[Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy]Levente Bodoki, Melinda Vincze, Zoltán Griger, et al.
Orvosi Hetilap|December 28, 2002
[Polymyositis/scleroderma autoantibody-positive scleroderma with dermatomyositis (scleromyositis)]László Török, Katalin Dankó, Gábor Cserni, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Orvosi Hetilap|September 17, 2011
[New therapeutic approaches for polymyositis and dermatomyositis]Katalin Dankó, Melinda Vincze
Orvosi Hetilap|July 26, 2016
[New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis]Andrea Váncsa, Katalin Dankó
Orvosi Hetilap|July 16, 2008
[Inclusion body myositis pathomechanism and therapy]Andrea Váncsa, Katalin Dankó
Clinical Rheumatology|August 5, 2004
Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlapAndrea Ponyi, Tamás Constantin, Katalin Dankó
Orvosi Hetilap|March 14, 2012
[Polymyositis-dermatomyositis recognized during the follow-up of a patient with type 2 diabetes]Francis Samer, Mária Csóka, Katalin Dankó
Orvosi Hetilap|August 30, 2017
[Clinical features and therapeutic response of our anti-SRP positive patients with myositis]Balázs Botos, Melinda Nagy-Vincze, Katalin Dankó
Expert Review of Clinical Pharmacology|July 11, 2017
Pharmacological management of dermatomyositisZoltán Griger, Melinda Nagy-Vincze, Katalin Dankó
Current Opinion in Rheumatology|September 17, 2014
Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic researchLisa G Rider, Katalin Dankó, Frederick W Miller
Orvosi Hetilap|May 8, 2013
[Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy]Levente Bodoki, Melinda Vincze, Zoltán Griger, et al.
Orvosi Hetilap|December 28, 2002
[Polymyositis/scleroderma autoantibody-positive scleroderma with dermatomyositis (scleromyositis)]László Török, Katalin Dankó, Gábor Cserni, et al.
Pageof 8